Multicenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:

Clinical trial NCT07608003 · RECRUITING

Trial details

NCT number: NCT07608003
Sponsor: Xiangya Hospital of Central South University
Status: RECRUITING
Study type: OBSERVATIONAL

Gliomas Harboring IDH1 and/or IDH2 Mutations Glioma Glioblastoma Multiforme Glioma of Brainstem Glioma, Diffuse Midline, H3K27M-mutant Glioma : Oligodendroglioma or Astrocytoma Gliomas

Start date: 2026-05-10
Primary completion: 2030-12-31
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.